.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Daiichi Sankyo
US Department of Justice
Chubb
Cerilliant
Accenture
QuintilesIMS
Boehringer Ingelheim
Dow

Generated: July 28, 2017

DrugPatentWatch Database Preview

KEFLET Drug Profile

« Back to Dashboard

Which patents cover Keflet, and what generic Keflet alternatives are available?

Keflet is a drug marketed by Lilly and is included in two NDAs.

The generic ingredient in KEFLET is cephalexin. There are twenty-nine drug master file entries for this compound. Sixty-two suppliers are listed for this compound. Additional details are available on the cephalexin profile page.

Summary for Tradename: KEFLET

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list33
Patent Applications: see list5,541
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:KEFLET at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly
KEFLET
cephalexin
TABLET;ORAL050440-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
KEFLET
cephalexin
TABLET;ORAL062745-001Dec 1, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
KEFLET
cephalexin
TABLET;ORAL050440-003Feb 26, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
KEFLET
cephalexin
TABLET;ORAL050440-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
KEFLET
cephalexin
TABLET;ORAL062745-002Dec 1, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Cantor Fitzgerald
US Army
Teva
Cipla
Queensland Health
Dow
Argus Health
Cerilliant
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot